The Long Case For AbbVie Inc. (ABBV)

AbbVie Inc. (NYSE:ABBV) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a market value of 122.87B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

AbbVie Inc. (NYSE:ABBV) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ABBV, the company currently has 3.55 billion of cash on the books, which is offset by 10.69 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 0 in total assets, balanced by 5.5 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

AbbVie Inc. saw 0 in free cash flow last quarter, representing a quarterly net change in cash of 5.51 billion. Perhaps most importantly where cash movements are concerned, the company saw about 0 in net operating cash flow.

AbbVie Inc. (NYSE:ABBV) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 8.28 billion in total revenues. That represents a quarterly year/year change in revenues of 0.16% in sequential terms, the ABBV saw sales decline by 0.04%.

But what about the bottom line? After all, that’s what really matters in the end. AbbVie Inc. is intriguing when broken down to its core data. The cost of selling goods last quarter was 1.93 billion, yielding a gross basic income of 6.34 billion. For shareholders, given the total diluted outstanding shares of 1.53B, this means overall earnings per share of 1260. Note, this compares with a consensus analyst forecast of 1.98 in earnings per share for its next fiscal quarterly report.

Is AbbVie Inc. (NYSE:ABBV) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 8.69 in total earnings per share. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on AbbVie Inc..

Previous ArticleNext Article

Related Post

China Pharma Holdings, Inc. (CPHI) Forming A Patte... China Pharma Holdings, Inc. (NYSE:CPHI) is in the highlights and many would want to know whether now might be a good time for it to present much upsid...
It’s worth it to have a look at American Air... American Airlines Group Inc. (NASDAQ:AAL) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a mar...
It’s worth it to have a look at Apple Inc. (... Apple Inc. (NASDAQ:AAPL) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participants trying to fig...
Checking Out the Fundamental Data for Whiting Petr... Whiting Petroleum Corporation (NYSE:WLL) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a mark...
The Fundamental Facts on Companhia de Saneamento B... Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (NYSE:SBS) seems to be forming a pattern of major movements, providing only some crumbs...